FindTrial
Sign In

Hyperthermia and condyloma accuminatum for the treatment of enormous condyloma accuminatum: multi-center, randomized, opened, paralled controlled trials

Hyperthermia and condyloma accuminatum for the treatment of enormous condyloma accuminatum: multi-center, randomized, opened, paralled controlled trials

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002586
Enrollment
Unknown
Registered
2012-09-16
Start date
2012-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

condyloma accuminatum

Interventions

test group:Hyperthermia
control group:carbon dioxide laser

Sponsors

The First Hospital, China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) age greater than 16 years old, male or female; (2) clinical diagnosis of genital warts, and wart diameter more than 2cm; (3) voluntary subjects signed informed consent.

Exclusion criteria

Exclusion criteria: (1) within 3 months after local or systemic treatment of patients; (2) HIV-infected; (3) the lesional skin combined with other infected; (5) a serious organ insufficiency, such as heart failure, renal failure, and other; (6) at the same time to participate in other clinical trials or the ongoing genital warts drug treatment; (7) the keeper of patient unbelievable or the patient be recognized will be poor compliance.

Design outcomes

Primary

MeasureTime frame
clinical cure rate of target lesion;—

Secondary

MeasureTime frame
VAS assessment of therapeutic misery index;—

Countries

China

Contacts

Public ContactXing-hua Gao
gaobarry@hotmail.com+86 13940152467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026